(Q35989747)

11 August 2017

1 reference

title

Management of primary intraocular lymphoma (English)

1 reference

11 August 2017

Stella K Kim

1

1 reference

11 August 2017

Chi-Chao Chan

series ordinal

2

1 reference

11 August 2017

Dana J Wallace

series ordinal

3

1 reference

11 August 2017

publication date

1 January 2005

1 reference

11 August 2017

published in

Current Oncology Reports

1 reference

11 August 2017

volume

7

1 reference

11 August 2017

issue

1

1 reference

11 August 2017

page(s)

74-79

1 reference

Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11912-005-0029-6

Intraocular lymphoma. Clinical and histopathologic diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-005-0029-6

Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-005-0029-6

Primary intraocular lymphoma (ocular reticulum cell sarcoma) diagnosis and management

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS11912-005-0029-6

21 January 2018

12 December 2020

Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS11912-005-0029-6

Pharmacokinetics and toxicity of intravitreal chemotherapy for primary intraocular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-005-0029-6

Variations in the presentation of primary intraocular lymphoma: case reports and a review

21 January 2018

1 reference

12 December 2020

Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment

1 reference

12 December 2020

Interleukin-10 and intraocular-central nervous system lymphoma

1 reference

12 December 2020

Update on the management of primary CNS lymphoma.

1 reference

12 December 2020

The clinical spectrum of ocular lymphoma

1 reference

12 December 2020

Intraocular lymphoma: update on diagnosis and management

1 reference

12 December 2020

Epidemiology of primary CNS lymphoma

1 reference

12 December 2020

1 reference

12 December 2020

Ocular and central nervous system lymphoma: clinical features and diagnosis

1 reference

12 December 2020

Combined modality therapy for primary CNS lymphoma

1 reference

12 December 2020

Vitreous cytokine levels

1 reference

12 December 2020

Interleukin-10 in the vitreous of patients with primary intraocular lymphoma

1 reference

12 December 2020

Intraventricular treatment of relapsed central nervous system lymphoma with the anti-CD20 antibody rituximab.

1 reference

12 December 2020

Chemotherapy in the management of intraocular lymphoma

1 reference

12 December 2020

Treatment of CNS lymphoma with the anti-CD20 antibody rituximab: experience with two cases and review of the literature

1 reference

12 December 2020

Primary CNS lymphoma: treatment with combined chemotherapy and radiotherapy

1 reference

12 December 2020

Intraocular methotrexate level after high-dose intravenous infusion

1 reference

12 December 2020

Fluorescein angiographic findings in primary intraocular lymphoma

1 reference

12 December 2020

Molecular pathology of primary intraocular lymphoma

1 reference

12 December 2020

Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315

1 reference

12 December 2020

The blood-ocular barriers

1 reference

12 December 2020

High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series

1 reference

12 December 2020

High-dose methotrexate for intraocular lymphoma.

1 reference

12 December 2020

Intraocular lymphoma: a series of 14 patients with clinicopathological features and treatment outcomes

1 reference

12 December 2020

Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement

1 reference

12 December 2020

Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma

1 reference

12 December 2020

Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10.

1 reference

12 December 2020

Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma

1 reference

12 December 2020

Combination treatment of intraocular lymphoma

1 reference

12 December 2020

The role of radiation therapy in the management of ocular reticulum cell sarcoma

1 reference

12 December 2020

Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab.

1 reference

12 December 2020

Primary central nervous system non-Hodgkin's lymphoma: survival advantages with combined initial therapy?

1 reference

12 December 2020

Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07.

1 reference

12 December 2020

Intraocular lymphoma.

1 reference

12 December 2020

Ocular manifestations of central nervous system lymphoma

1 reference

12 December 2020

Primary ocular lymphoma: clinical features, diagnosis, and treatment.

1 reference

12 December 2020

Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment

1 reference

12 December 2020

Intraocular levels of methotrexate after intravenous administration

1 reference

12 December 2020

Treatment of intraocular lymphoma with high-dose Ara-C

1 reference

12 December 2020

Long-term survival in primary CNS lymphoma

1 reference

12 December 2020

Primary central nervous system lymphoma: age and performance status are more important than treatment modality

1 reference

12 December 2020

Relevance of intraocular involvement in the management of primary central nervous system lymphomas

1 reference

12 December 2020

Characterization of vitreous B-cell infiltrates in patients with primary ocular lymphoma, using CDR3 size polymorphism analysis of antibody transcripts

1 reference

12 December 2020

Intrathecal chemotherapy for recurrent central nervous system intraocular lymphoma

1 reference

12 December 2020

Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis

1 reference

12 December 2020

10.1007/S11912-005-0029-6

Identifiers

DOI

1 reference

11 August 2017

1 reference